The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Irina A. Vasilevskaya

Abramson Family Cancer Center

University of Pennsylvania

1020 BRB II/III

421 Curie Blvd.

USA

[email]@*.med.upenn.edu

Name/email consistency: high

[Claim this account]

Affiliations

Abramson Family Cancer Center, University of Pennsylvania, 1020 BRB II/III, 421 Curie Blvd., USA. 2005 - 2008
Department of Medicine, University of Pennsylvania, Philadelphia 19104, USA. 1999 - 2004

References

Disruption of signaling through SEK1 and MKK7 yields differential responses in hypoxic colon cancer cells treated with oxaliplatin. Vasilevskaya, I.A., Selvakumaran, M., O'Dwyer, P.J. Mol. Pharmacol. (2008) [Pubmed]
17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines. Vasilevskaya, I.A., O'Dwyer, P.J. Biochem. Pharmacol. (2005) [Pubmed]
Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines. Vasilevskaya, I.A., Rakitina, T.V., O'Dwyer, P.J. Mol. Pharmacol. (2004) [Pubmed]
Geldanamycin and its 17-allylamino-17-demethoxy analogue antagonize the action of Cisplatin in human colon adenocarcinoma cells: differential caspase activation as a basis for interaction. Vasilevskaya, I.A., Rakitina, T.V., O'Dwyer, P.J. Cancer Res. (2003) [Pubmed]
Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells. Vasilevskaya, I.A., O'Dwyer, P.J. Cancer Res. (1999) [Pubmed]